Testing effectiveness (Phase 2)Looking for participantsNCT05583708
What this trial is testing
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
Who this might be right for
Merkel Cell Carcinoma
Weill Medical College of Cornell University 18